» Articles » PMID: 18036614

Human Intestinal Maltase-glucoamylase: Crystal Structure of the N-terminal Catalytic Subunit and Basis of Inhibition and Substrate Specificity

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2007 Nov 27
PMID 18036614
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Human maltase-glucoamylase (MGAM) is one of the two enzymes responsible for catalyzing the last glucose-releasing step in starch digestion. MGAM is anchored to the small-intestinal brush-border epithelial cells and contains two homologous glycosyl hydrolase family 31 catalytic subunits: an N-terminal subunit (NtMGAM) found near the membrane-bound end and a C-terminal luminal subunit (CtMGAM). In this study, we report the crystal structure of the human NtMGAM subunit in its apo form (to 2.0 A) and in complex with acarbose (to 1.9 A). Structural analysis of the NtMGAM-acarbose complex reveals that acarbose is bound to the NtMGAM active site primarily through side-chain interactions with its acarvosine unit, and almost no interactions are made with its glycone rings. These observations, along with results from kinetic studies, suggest that the NtMGAM active site contains two primary sugar subsites and that NtMGAM and CtMGAM differ in their substrate specificities despite their structural relationship. Additional sequence analysis of the CtMGAM subunit suggests several features that could explain the higher affinity of the CtMGAM subunit for longer maltose oligosaccharides. The results provide a structural basis for the complementary roles of these glycosyl hydrolase family 31 subunits in the bioprocessing of complex starch structures into glucose.

Citing Articles

Elucidation of α-glucosidase inhibitory activity and UHPLC-ESI-QTOF-MS based metabolic profiling of endophytic fungi BRN05 isolated from seeds of king.

Kumar P, Kannakazhi Kantari S, Biswal R, Ghanta P, Dharanikota M Front Fungal Biol. 2025; 6:1447609.

PMID: 39944407 PMC: 11811940. DOI: 10.3389/ffunb.2025.1447609.


Computational Exploration of Phenolic Compounds from Endophytic Fungi as α-Glucosidase Inhibitors for Diabetes Management.

Kannakazhi Kantari S, Kanchi S, Patnaik B, Agraharam A ACS Omega. 2025; 10(1):1279-1292.

PMID: 39829537 PMC: 11740116. DOI: 10.1021/acsomega.4c08872.


Discovery of α-amylase and α-glucosidase dual inhibitors from NPASS database for management of Type 2 Diabetes Mellitus: A chemoinformatic approach.

Ndarawit W, Ochieng C, Angwenyi D, Cruz J, Santos C, Kimani N PLoS One. 2024; 19(11):e0313758.

PMID: 39541274 PMC: 11563405. DOI: 10.1371/journal.pone.0313758.


Click Reaction Inspired Enzyme Inhibitors in Diabetes Care: An Update in the Field of Chronic Metabolic Disorder.

Mudgal D, Yadav N, Srivastava G, Mishra M, Mishra V Curr Pharm Des. 2024; 31(4):261-291.

PMID: 39410885 DOI: 10.2174/0113816128310031240923062555.


Multireceptor Analysis for Evaluating the Antidiabetic Efficacy of Karanjin: A Computational Approach.

Nag S, Stany B, Mishra S, Kumar S, Mohanto S, Ahmed M Endocrinol Diabetes Metab. 2024; 7(4):e509.

PMID: 38982323 PMC: 11233261. DOI: 10.1002/edm2.509.